News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
en
Crystal Bio's CSO, Billy Wu, Ph.D. will be in San Francisco with Crystal Pharmatech's BD Director, Chris Heard, for the American Association of Pharmaceutical Scientists (AAPS) | @aapscomms National Biotechnology Conference.
Discuss US-based biologics analytical services including:
· Antibody-based biologics
· Novel combinations of ADC and cell/gene therapy
· Ligand binding assays with LC-MS for serum stability and PK/PD-related analysis
Ready for an evening of unscripted connection?
Please complete the form to register for our San Diego Biotech and Pharma R&D social. Note: Registration is subject to review. You will receive a formal confirmation email once your attendance is approved.
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your registration. The information you submit will be governed by our Privacy Policy.
_.webp "A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs")
Subscribe to be the first to get the updates!
